Call (305) 434-2647
Understand the Evidence. Know Your Options.
At Miami Stem Cell Clinic, we believe patients should receive clear, balanced information before making decisions about their care.
Our physician-led approach considers your condition, medical history, relevant clinical evidence, and individual goals before discussing potential treatment options.
We aim to explain what is known, what remains uncertain, and which alternatives may be appropriate for your circumstances.

We believe treatment decisions should be guided by clinical evidence, individual assessment,
and a clear understanding of available options.
Understand what a proposed intervention involves, including the product or preparation used.
Review relevant human research, reported outcomes, and important limitations.
Discuss potential risks, uncertainties, treatment burdens, and appropriate alternatives.
Clarify the intervention's regulatory status and availability at the intended treatment location.
What the Research Can — and Cannot — Tell Us
Medical research can help clinicians understand the potential benefits and limitations of different interventions.
However, results may vary depending on the product, condition, patient population, and treatment method studied.
Evidence supporting one preparation or indication cannot automatically be applied to another.
We believe patients should understand both the findings and the uncertainties before considering a particular intervention.
Key Considerations:
Relevant human clinical research.
Outcomes studied, including pain and physical function.
Study limitations and conflicting findings.
Relevance to the individual patient's condition.
Important: A proposed biological mechanism or promising early research finding does not, by itself, establish clinical effectiveness.

Understanding What Is Being Considered
Regenerative medicine encompasses different types of products, preparations, and clinical approaches.
These may vary in their biological source, composition, preparation, intended use, and regulatory status.
For example, platelet-rich plasma, extracellular vesicle preparations, and living-cell products should not be considered interchangeable.
Before a specific intervention is considered, patients should understand exactly what is proposed and what evidence supports its intended use.
Key Considerations:
Regenerative medicine encompasses different types of products, preparations, and clinical approaches.
These may vary in their biological source, composition, preparation, intended use, and regulatory status.
For example, platelet-rich plasma, extracellular vesicle preparations, and living-cell products should not be considered interchangeable.
Before a specific intervention is considered, patients should understand exactly what is proposed and what evidence supports its intended use.
Key Considerations:
Exact product or intervention identity.
Biological source and composition, where relevant.
Intended clinical use and proposed administration.
Supporting evidence and regulatory status.
Important: Evidence for one product or preparation should not be used to imply that another product is equally safe or effective.

Making an Informed Clinical Decision
Every intervention should be considered in the context of the patient's condition, medical history, clinical findings, and available evidence.
A balanced discussion includes potential benefits, important risks, uncertainties, reasonable alternatives, and the option of not proceeding when appropriate.
No single treatment is suitable for every patient, and no particular outcome can be guaranteed.
Key Considerations:
Intended benefits and evidence supporting them.
Potential adverse effects, risks, and limitations.
Recovery, follow-up, and treatment-related burdens.
Conventional care, rehabilitation, and specialist alternatives.
Before any intervention, the treating clinician should explain the relevant information and obtain informed consent.

Understanding Your Consultation Location
Clinical services, regulatory requirements, and treatment availability may differ between Miami and London.
An intervention discussed in one location should not automatically be assumed to be available, authorized, or appropriate in another.
Any specific treatment proposal requires confirmation of the responsible clinician, intended location, relevant regulatory status, and individual clinical suitability.
Key Considerations:
Confirmation of the intended treating location.
Identification of the accountable clinician.
Verification of applicable regulatory status.
Confirmation of location-specific service availability.
Important: Specific treatment availability in Miami or London must be confirmed with the respective clinical team. A product's status or lawful use in one jurisdiction does not automatically apply in another.

Understanding the proposed treatment is an important part of informed decision-making.
Patients may wish to discuss the following questions before deciding whether to proceed:
What is the exact intervention or product being proposed?
What clinical evidence supports its use for my condition?
What are the potential benefits, risks, and limitations?
What established alternatives should I consider?
What is the regulatory status of the proposed intervention?
Is the intervention available at my chosen location?
What recovery, follow-up, or additional care may be required?
Find answers to common questions about treatment evidence, regulatory considerations, and informed clinical decisions.

Treatment transparency means providing clear information about a proposed intervention, including its identity, supporting evidence, regulatory status, potential risks, limitations, and alternatives.
No. Regenerative treatments may differ in their composition, preparation, intended use, and supporting evidence. The findings for one product or procedure cannot automatically be applied to another.
No. No specific outcome can be guaranteed. Suitability and expected outcomes depend on the intervention, underlying condition, clinical findings, and available evidence.
No. Regulatory status depends on the specific product, intended use, and jurisdiction. The status of any proposed intervention should be confirmed before treatment.
A clinician considers symptoms, medical history, examination findings, relevant investigations, available evidence, risks, and reasonable treatment alternatives.
Appropriate alternatives may include conservative management, rehabilitation, specialist referral, or other established approaches. The option of not proceeding should also be discussed where appropriate.
Not necessarily. Clinical services and regulatory requirements may differ between locations. Specific availability must be confirmed with the responsible clinical team.
You do not need to choose a treatment before contacting the clinic.
A thoughtful clinical assessment can help clarify your concerns, explain relevant evidence,
and support an informed discussion about appropriate next steps.
© 2026 Miami Stem Cell Clinic. All rights reserved.
Distinct organizations: